Clinical Trial

Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study: obtaining knowledge about the impact of Snoezelen® therapy on the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol. The main questions it aims to answer are: Does Snoezelen therapy improve the health of adults suffering from schizophrenia and requiring permanent institutional care, adults suffering from schizophrenia and adults (women) addicted to alcohol? The participant will participate in Snoezelen® therapy for 6 or 12 weeks, 2 times a week (30 minutes each session).
Trial Details
NCT Number NCT07748078
Lead Sponsor The Jerzy Kukuczka Academy of Physical Education in Katowice
Collaborators: Clinical Psychiatric Hospital SPZOZ in Rybnik, Poland
Conditions SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder, Alcohol Dependence (Primary Condition)
Enrollment 140 participants
Start Date 2026-09-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05